To treat complicated intra-abdominal infections in patients 18 years and older adults Eravacycline a therapy noted to have a wide profile of antibacterial activity has got a green signal. The efficacy and safety of it were established in non-inferiority studies by comparing it to the therapies like ertapenem and meropenem which were used widely. Intra-Abdominal Infections include a host of infectious processes along with peritonitis diverticulitis cholangitis and pancreatitis. It has been termed as complicated in case if the infection extends beyond the source of the organ into the peritoneal space or other gastrointestinal tract-related issues. The experts suggest early
